Outcomes of salvage re-irradiation in recurrent medulloblastoma correlate with age at initial diagnosis, primary risk-stratification, and molecular subgrouping.
Tejpal GuptaMadan MaitreGoda Jayant SastriRahul KrishnatryNeelam ShirsatSridhar EpariAyushi SahayGirish ChinnaswamyVijay PatilPrakash ShettyAliasgar MoiyadiPublished in: Journal of neuro-oncology (2019)
Salvage re-RT provides good local control and encouraging survival outcomes with acceptable toxicity in selected patients with recurrent/progressive MB.